![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Erickson, Nicole; Schinkoethe, T.; Eckhardt, C.; Storck, L.; Joos, A.; Liu, L.; Ballmer, P. E.; Mumm, F.; Fey, T. und Heinemann, V.
(2021):
Patient-reported outcome measures obtained via E-Health tools ease the assessment burden and encourage patient participation in cancer care (PaCC Study).
In: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Bd. 29, Nr. 12: S. 7715-7724
[PDF, 768kB]
Dreyling, M.; Morschhauser, F.; Bouabdallah, K.; Bron, D.; Cunningham, D.; Assouline, S. E.; Verhoef, G.; Linton, K.; Thieblemont, C.; Vitolo, U.; Hiemeyer, F.; Giurescu, M.; Garcia-Vargas, J.; Gorbatchevsky, I.; Liu, L.; Koechert, K.; Pena, C.; Neves, M.; Childs, B. H. und Zinzani, P. L.
(2017):
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.
In: Annals of Oncology, Bd. 28, Nr. 9: S. 2169-2178
Liu, L.; Köchert, K.; Seidel, H.; Garcia-Vargas, J.; Childs, B. H.; Follows, G.; Bouabdallah, K.; Dreyling, M. und Pena, C.
(2017):
Tumor gene expression signatures of BCR/PI3K dependence in association with copanlisib monotherapy activity in heavily pretreated patients with indolent NHL and follicular lymphoma.
In: Annals of Oncology, Bd. 28
Liu, L.; Koechert, K.; Cheng, J.; Garcia-Vargas, J.; Childs, B. H.; Dreyling, M. und Pena, C.
(2016):
Tumor gene expression profiles associated with single-agent copanlisib activity in heavily pretreated patients with indolent and aggressive non-hodgkin lymphoma (NHL).
In: Haematologica, Bd. 101: S. 571